Arch Biopartners Inc Cash Flow Conversion Efficiency

Latest as of March 2024: 0.072x

Arch Biopartners Inc cash flow conversion efficiency. Based on the latest financial reports, Arch Biopartners Inc (ARCH) has a cash flow conversion efficiency ratio of 0.072x as of March 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-465.38K ≈ $-336.65K USD) by net assets (CA$-6.44 Million ≈ $-4.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Arch Biopartners Inc (1997–2023)

Cash flow conversion efficiency of Arch Biopartners Inc from 1997 to 2023. This chart illustrates how Arch Biopartners Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Arch Biopartners Inc share price for real-time trading data and today's change.

Arch Biopartners Inc Cash Flow Conversion Ratio Explained

Arch Biopartners Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Arch Biopartners Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Arch Biopartners Inc ranked by their cash flow conversion efficiency. Also see ARCH stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
JP Morgan Global Growth & Income PLC LSE:JGGI	0.004x
Sportsmans NASDAQ:SPWH	0.078x
Lion One Metals Limited V:LIO	-0.011x
Omesti Bhd KLSE:9008	0.045x
Diginex Limited Ordinary Shares NASDAQ:DGNX	-0.503x
ATA IMS Bhd KLSE:8176	0.025x
Ralco Agencies Ltd TA:RLCO	0.141x
BrilliA Inc NYSE MKT:BRIA	N/A

Annual Cash Flow Conversion Efficiency for Arch Biopartners Inc (1997–2023)

The table below shows the annual cash flow conversion efficiency of Arch Biopartners Inc from 1997 to 2023. Review ARCH free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2023-09-30	CA$-5.51 Million ≈ $-3.99 Million	CA$-234.07K ≈ $-169.33K	0.042x	-82.41%
2022-09-30	CA$-4.47 Million ≈ $-3.23 Million	CA$-1.08 Million ≈ $-781.28K	0.242x	-68.53%
2021-09-30	CA$-3.88 Million ≈ $-2.81 Million	CA$-2.98 Million ≈ $-2.16 Million	0.768x	+55.91%
2020-09-30	CA$-3.87 Million ≈ $-2.80 Million	CA$-1.90 Million ≈ $-1.38 Million	0.492x	-20.82%
2019-09-30	CA$-2.90 Million ≈ $-2.10 Million	CA$-1.80 Million ≈ $-1.31 Million	0.622x	-79.66%
2018-09-30	CA$-1.05 Million ≈ $-756.50K	CA$-3.20 Million ≈ $-2.31 Million	3.058x	+126.66%
2017-09-30	CA$-563.41K ≈ $-407.56K	CA$-760.17K ≈ $-549.89K	1.349x	-52.55%
2016-09-30	CA$-256.91K ≈ $-185.85K	CA$-730.53K ≈ $-528.45K	2.843x	+184.73%
2015-09-30	CA$141.48K ≈ $102.34K	CA$-474.82K ≈ $-343.47K	-3.356x	-105.55%
2014-09-30	CA$-6.58K ≈ $-4.76K	CA$-398.51K ≈ $-288.27K	60.517x	+14513.69%
2013-09-30	CA$-425.37K ≈ $-307.70K	CA$-176.15K ≈ $-127.42K	0.414x	-49.91%
2012-09-30	CA$-355.42K ≈ $-257.10K	CA$-293.82K ≈ $-212.55K	0.827x	-51.89%
2011-09-30	CA$-174.98K ≈ $-126.58K	CA$-300.68K ≈ $-217.51K	1.718x	+237.73%
2010-09-30	CA$164.87K ≈ $119.26K	CA$-205.71K ≈ $-148.81K	-1.248x	-207.77%
2009-09-30	CA$-345.96K ≈ $-250.26K	CA$-400.53K ≈ $-289.74K	1.158x	+718.19%
2008-09-30	CA$-1.77 Million ≈ $-1.28 Million	CA$-251.16K ≈ $-181.69K	0.142x	-5.56%
2007-09-30	CA$-1.01 Million ≈ $-732.95K	CA$-151.81K ≈ $-109.82K	0.150x	+180.51%
2006-09-30	CA$-644.38K ≈ $-466.14K	CA$119.92K ≈ $86.75K	-0.186x	-135.10%
2005-09-30	CA$-887.26K ≈ $-641.83K	CA$-470.38K ≈ $-340.27K	0.530x	-64.76%
2004-09-30	CA$-639.29K ≈ $-462.45K	CA$-961.78K ≈ $-695.74K	1.504x	+139.16%
2003-09-30	CA$73.10K ≈ $52.88K	CA$-280.87K ≈ $-203.17K	-3.842x	+82.41%
2002-09-30	CA$17.10K ≈ $12.37K	CA$-373.42K ≈ $-270.13K	-21.841x	-1484.77%
2001-09-30	CA$-159.43K ≈ $-115.33K	CA$-251.46K ≈ $-181.90K	1.577x	+501.48%
2000-09-30	CA$2.05 Million ≈ $1.48 Million	CA$-803.47K ≈ $-581.22K	-0.393x	+50.09%
1999-09-30	CA$1.06 Million ≈ $766.49K	CA$-834.06K ≈ $-603.34K	-0.787x	-120.14%
1998-09-30	CA$-128.74K ≈ $-93.13K	CA$-503.20K ≈ $-364.01K	3.909x	-91.29%
1997-09-30	CA$-22.22K ≈ $-16.07K	CA$-997.15K ≈ $-721.32K	44.884x	--

About Arch Biopartners Inc

V:ARCH Canada Biotechnology

Market Cap

$40.79 Million

CA$56.38 Million CAD

Market Cap Rank

#22463 Global

#793 in Canada

Share Price

CA$0.83

Change (1 day)

+2.47%

52-Week Range

CA$0.41 - CA$1.45

All Time High

CA$5.00